These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 7507039)

  • 1. Tropisetron. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential as an antiemetic.
    Lee CR; Plosker GL; McTavish D
    Drugs; 1993 Nov; 46(5):925-43. PubMed ID: 7507039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tropisetron (Navoban) alone and in combination with dexamethasone in the prevention of chemotherapy-induced emesis: the Nordic experience.
    Sorbe BG
    Semin Oncol; 1994 Oct; 21(5 Suppl 9):20-6. PubMed ID: 9113123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tropisetron: an update of its use in the prevention of chemotherapy-induced nausea and vomiting.
    Simpson K; Spencer CM; McClellan KJ
    Drugs; 2000 Jun; 59(6):1297-315. PubMed ID: 10882164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of chemotherapy-induced nausea and vomiting by tropisetron (Navoban) alone or in combination with other antiemetic agents.
    Bruntsch U; Drechsler S; Eggert J; Gosse H; Ukena D; Imhoff W; Faerber L
    Semin Oncol; 1994 Oct; 21(5 Suppl 9):7-11. PubMed ID: 9113120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A report comparing the use of tropisetron (Navoban), a 5-HT3 antagonist, with a standard antiemetic regimen of dexamethasone and metoclopramide in cisplatin-treated patients under conditions of severe emesis.
    Madej G; Krzakowski M; Pawinski A; Lasota W; Rogowski W; Skoneczna I
    Semin Oncol; 1994 Oct; 21(5 Suppl 9):3-6. PubMed ID: 9113119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the efficacy of tropisetron versus a metoclopramide cocktail based on the intensity of cisplatin-induced emesis.
    Chang TC; Hsieh F; Lai CH; Tseng CJ; Cheng HH; Li CL; Michael BJ; Soong YK
    Cancer Chemother Pharmacol; 1996; 37(3):279-85. PubMed ID: 8529290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized, multicenter study comparing the efficacy and tolerability of tropisetron, a new 5-HT3 receptor antagonist, with a metoclopramide-containing antiemetic cocktail in the prevention of cisplatin-induced emesis.
    Sorbe BG; Högberg T; Glimelius B; Schmidt M; Wernstedt L; Hansen O; Sörensen BT; Räisänen I; van Oosterom AT; de Bruijn KM
    Cancer; 1994 Jan; 73(2):445-54. PubMed ID: 8293412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective randomized comparison of tropisetron with and without dexamethasone against high-dose metoclopramide in prophylaxis of acute and delayed cisplatin-induced nausea and vomiting.
    Malik I; Moid I; Khan Z; Hussain M
    Am J Clin Oncol; 1999 Apr; 22(2):126-30. PubMed ID: 10199444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tropisetron compared with a metoclopramide-based regimen in the prevention of chemotherapy-induced nausea and vomiting.
    Anderson H; Thatcher N; Howell A; Logan K; Sage T; de Bruijn KM
    Eur J Cancer; 1994; 30A(5):610-5. PubMed ID: 8080674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An open multicentre study of tropisetron for cisplatin-induced nausea and vomiting.
    Olver IN; Craft PS; Clingan PR; Kearsley JH; Planner RS; van Hazel GA; Bell DR; Adena MR; Hall BE; Pearson LL
    Med J Aust; 1996 Mar; 164(6):337-40. PubMed ID: 8606657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tropisetron in the prevention of chemotherapy-induced nausea and vomiting in patients responding poorly to previous conventional antiemetic therapy.
    Bruntsch U; Rüfenacht E; Parker I; Drechsler S; de Bruijn K
    Ann Oncol; 1993; 4 Suppl 3():25-9. PubMed ID: 8363995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Granisetron. An update of its therapeutic use in nausea and vomiting induced by antineoplastic therapy.
    Yarker YE; McTavish D
    Drugs; 1994 Nov; 48(5):761-93. PubMed ID: 7530631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current issues in the management of nausea and vomiting.
    Gralla RJ
    Ann Oncol; 1993; 4 Suppl 3():3-7. PubMed ID: 8363996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of emesis by tropisetron (Navoban) in children receiving cytotoxic therapy for solid malignancies.
    Otten J; Hachimi-Idrissi S; Balduck N; Maurus R
    Semin Oncol; 1994 Oct; 21(5 Suppl 9):17-9. PubMed ID: 9113122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tropisetron plus haloperidol to ameliorate nausea and vomiting associated with high-dose alkylating agent cancer chemotherapy.
    Bregni M; Siena S; Di Nicola M; Bonadonna G; Gianni AM
    Eur J Cancer; 1991; 27(5):561-5. PubMed ID: 1828962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Study of efficacy and tolerability of tropisetron in the prevention of cisplatin induced nausea and vomiting.
    Chiersilpa A; Ngow J
    J Med Assoc Thai; 1999 Sep; 82(9):915-21. PubMed ID: 10561949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An open, randomized study to compare the efficacy and tolerability of tropisetron with that of a metoclopramide-containing antiemetic cocktail in the prevention of cisplatin-induced emesis.
    Sorbe B; Hallén C; Frankendal B
    Cancer Chemother Pharmacol; 1994; 33(4):298-302. PubMed ID: 8281622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of chemotherapy-induced nausea and emesis in patients responding poorly to previous antiemetic therapy. Comparing tropisetron with optimised standard antiemetic therapy.
    Bruntsch U; Drechsler S; Hiller E; Eiermann W; Tulusan AH; Bühner M; Hartenstein R; Koenig HJ; Gallmeier WM
    Drugs; 1992; 43 Suppl 3():23-6. PubMed ID: 1380429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The development of tropisetron in its clinical perspective.
    de Bruijn KM
    Ann Oncol; 1993; 4 Suppl 3():19-23. PubMed ID: 8363994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A study evaluating the efficacy and tolerability of tropisetron in combination with dexamethasone in the prevention of delayed platinum-induced nausea and emesis.
    Sorbe BG; Berglind AM; Andersson H; Boman K; Högberg T; Hallgren M; Schmidt M
    Cancer; 1998 Sep; 83(5):1022-32. PubMed ID: 9731907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.